Mon - Fri 09:00-18:00 0207 060 3773
Email info@boundarycapital.com

Month

October 2015
Boundary Capital Partners has announced it is raising a £10m fund to invest further into British technology and life science businesses. It will be the fourth in the successful line of Boundary Capital funds. The AngelPlus fund is an evergreen fund designed to give investors access to a portfolio of early stage technology and life...
Read More
Two industry leaders have been appointed partners at early-stage venture capital firm Boundary Capital. Dr Adrian Parton MBE and Grant Hawthorne are both key influencers in their respective fields of biotechnology and investment. The appointments mark an increase in UK investments made by Boundary Capital in 2015 and the launch of their new SEIS fund...
Read More
Boundary Capital has joined other UK angels and VCs to pump $2.15 million into Cambridge-born Desktop Genetics (DTG). The Investment will accelerate development of the startup’s DESKGEN genome editing software platform. The platform aims to revolutionise the way genetic researchers carry out gene editing experiments. The cash comes from a syndicate of VCs and angel...
Read More

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases